1. |
Fineberg SE, Kawabata TT, Finco-Kent D, et al. Immunological responses to exogenous insulin. Endocr Rev, 2007, 28: 625-652.
|
2. |
Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract, 2009, 83(1): e19-20.
|
3. |
Van Haeften TW. Clinical significance of insulin antibodies in insulin-treated diabetic patients. Diabetes Care, 1989, 12: 641-648.
|
4. |
Lahtela JT, Knip M, Paul R, et al. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. Diabetes Care, 1997, 20: 71-73.
|
5. |
Asai M, Kodera T, Ishizeki K, et al. Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance. Diabetes Res Clin Pract, 2003, 61: 89-92.
|
6. |
Dahl-Jorgensen K, Torjesen P, Hanssen KF, et al. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes,1987, 36: 1-5.
|
7. |
Van Haeften TW, Krom BA, Gerich JE. Prolonged fasting hypoglycemia due to insulin antibodies in patients with non-insulindependent diabetes mellitus: effect of insulin withdrawal on insulinantibody- binding kinetics. Diabetes Care, 1987, 10: 160-163.
|
8. |
Hara K, Tobe K, Uchigata Y, et al. Antibody-mediated insulin resistance treated by cessation of insulin administration. Intern Med, 2000, 39: 143-145.
|
9. |
Virgili F, Frigato F, Magnanini PG, et al. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins. Diabetes Res, 1988, 9: 19-20.
|
10. |
Jovanovic-Peterson L, Kitzmiller JL, Peterson CM. Randomized trial of human versus animal species insulin in diabetic pregnant women: improved glycemic control, not fewer antibodies to insulin, influences birth weight. Am J Obstet Gynecol, 1992, 167: 1325-1330.
|
11. |
Ishizuka T, Ogawa S, Mori T, et al. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Res Clin Pract, 2009, 84(2): e21-23.
|
12. |
Matsuyoshi A, Shimoda S, Tsuruzoe K, et al. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy. Diabetes Res Clin Pract, 2006, 72: 238-243.
|
13. |
Koyama R, Nakanishi K, Kato M, et al. Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone. Am J Med Sci, 2005, 329: 259-264.
|
14. |
MacLeish SA, Wallace S, Madhun Z, et al. Treatment of hypoglycemia with intramuscular immunoglobulin in insulin dependent-diabetics with insulin antibodies. Journal of Allergy and Clinical Immunology, 2007, 119(1) Suppl 1: S18.
|
15. |
Miyamura N, Murata Y, Taketa K, et al. A case of insulin autoimmune syndrome with HLA DRB1*0404: impact on the hypothesis for the molecular pathogenesis involving the DRB1 molecules. Diabetes Med, 2006, 23: 104-105.
|